Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, United States
Miklós Békés
Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, United States
Jessica R Chapman
Proteomics Laboratory, Division of Advanced Research Technologies, New York University School of Medicine, New York, United States
Sarah B Crist
Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, United States
Mathew JK Jones
Molecular Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, Unites States
Beatrix M Ueberheide
Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, United States; Proteomics Laboratory, Division of Advanced Research Technologies, New York University School of Medicine, New York, United States
NEDD8 is a ubiquitin-like modifier most well-studied for its role in activating the largest family of ubiquitin E3 ligases, the cullin-RING ligases (CRLs). While many non-cullin neddylation substrates have been proposed over the years, validation of true NEDD8 targets has been challenging, as overexpression of exogenous NEDD8 can trigger NEDD8 conjugation through the ubiquitylation machinery. Here, we developed a deconjugation-resistant form of NEDD8 to stabilize the neddylated form of cullins and other non-cullin substrates. Using this strategy, we identified Ubc12, a NEDD8-specific E2 conjugating enzyme, as a substrate for auto-neddylation. Furthermore, we characterized SENP8/DEN1 as the protease that counteracts Ubc12 auto-neddylation, and observed aberrant neddylation of Ubc12 and other NEDD8 conjugation pathway components in SENP8-deficient cells. Importantly, loss of SENP8 function contributes to accumulation of CRL substrates and defective cell cycle progression. Thus, our study highlights the importance of SENP8 in maintaining proper neddylation levels for CRL-dependent proteostasis.